Foghorn Therapeutics Inc. (FHTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of FHTX. The 7-day demo opens the 1M and 3M ranges and puts FHTX on your watchlist.
Start 7-day demoLatest FHTX insider trades
Thomas J. Lynch Jr.Grant or award$114K- Stuart DutyGrant or award$114K
Scott BillerGrant or award
About Foghorn Therapeutics Inc. (FHTX)
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
- CAMBRIDGE, MA
- 106
- 2020
- XNAS
FHTX Form 4 activity by transaction type, last 90 days
No Form 4 activity for FHTX in the last 90 days.
FHTX insider transactions (Form 4)
2623 Form 4 filings on record, the earliest from Dec 30, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Thomas J. Lynch Jr. | Grant or award | Stock Options (Right to buy) | 28,000 | $4.08 | $114K | |
| Stuart Duty | Grant or award | Stock Options (Right to buy) | 28,000 | $4.08 | $114K | |
| Scott Biller | Grant or award | Stock Options (Right to buy) | 28,000 | $4.08 | $114K | |
| Neil Gallagher | Grant or award | Stock Options (Right to buy) | 28,000 | $4.08 | $114K | |
 Michael Mendelsohn | Grant or award | Stock Options (Right to buy) | 28,000 | $4.08 | $114K | |
 Ian F. Smith | Grant or award | Stock Options (Right to buy) | 28,000 | $4.08 | $114K | |
 Simba Gill | Grant or award | Stock Options (Right to buy) | 28,000 | $4.08 | $114K | |
 B. Lynne Parshall | Grant or award | Stock Options (Right to buy) | 28,000 | $4.08 | $114K | |
| Douglas G. Cole | Grant or award | Stock Options (Right to buy) | 28,000 | $4.08 | $114K | |
| Adrian Gottschalk - Officer | Gift | Common Stock | 47,497 | $0.00 | - | |
| Adrian Gottschalk - Officer | Gift | Common Stock | 47,497 | $0.00 | - | |
| Adrian Gottschalk - Officer | Gift | Common Stock | 59,208 | $0.00 | - | |
| Adrian Gottschalk - Officer | Gift | Common Stock | 59,208 | $0.00 | - | |
| Ryan D. Maynard - Officer | Grant or award | Stock Option (right to buy) | 400,000 | $5.75 | $2.30M | |
| Adrian Gottschalk - Officer | Grant or award | Stock option (right to buy) | 1,075,000 | $5.23 | $5.62M | |
| Carlos Costa - Officer | Grant or award | Stock option (right to buy) | 230,000 | $5.71 | $1.31M | |
| Michael Lacascia - Officer | Grant or award | Stock option (right to buy) | 295,000 | $5.71 | $1.68M | |
| Alfonso Quintas Cardama - Officer | Grant or award | Stock option (right to buy) | 300,000 | $5.71 | $1.71M | |
| Anna Rivkin - Officer | Grant or award | Stock option (right to buy) | 165,000 | $5.71 | $942K | |
| Steven F. Bellon - Officer | Grant or award | Stock Option (right to buy) | 300,000 | $5.71 | $1.71M | |
| Flagship Pioneering, LLC | Grant or award | Pre-Funded Warrants to purchase Common Stock | 2,235,468 | $6.71 footnote F1 | $15.00M | |
| Flagship Pioneering, LLC | Grant or award | Series 1 Warrants to purchase Common Stock | 1,117,734 | - footnote F1 | - | |
| Flagship Pioneering, LLC | Grant or award | Series 2 Warrants to purchase Common Stock | 1,117,734 | - footnote F1 | - | |
| ||||||
| Ian F. Smith | Grant or award | Stock Option (right to buy) | 25,000 | $4.79 | $120K | |
| Simba Gill | Grant or award | Stock Option (right to buy) | 25,000 | $4.79 | $120K | |
| B. Lynne Parshall | Grant or award | Stock Option (right to buy) | 25,000 | $4.79 | $120K | |
FHTX insider trading FAQ
What is the latest insider trade for FHTX?
Foghorn Therapeutics Inc. (FHTX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-25. The full record for FHTX runs to 23 Form 4 filings, the earliest from 2024-12-30. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying FHTX stock?
No insider purchases of FHTX were filed in the last 90 days.
How many insiders are selling FHTX stock?
No insider sales of FHTX were filed in the last 90 days.
Where can I see FHTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects FHTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Thomas J. Lynch Jr. view on EDGAR
- - Stuart Duty view on EDGAR
- - Scott Biller view on EDGAR
- - Neil Gallagher view on EDGAR
- - Michael Mendelsohn view on EDGAR
- - Ian F. Smith view on EDGAR
- - Simba Gill view on EDGAR
- - B. Lynne Parshall view on EDGAR
- - Douglas G. Cole view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where FHTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow FHTX with a 7-day demo
- FHTX on your watchlist
- Every FHTX Form 4 filing on record
- Up to 3 months of FHTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
